Renal nerve ablation as a tool for studying the interactions between arterial stiffness, blood pressure and sympathetic drive: Weight of the evidence

Journal of Hypertension

Volumn 31, Issue 9, 2013, Pages 1782-1784

  Grassi, Guido ^a,b   Mancia, Giuseppe ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLEPHRINE;

ADRENERGIC SYSTEM; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY WALL; AUGMENTATION INDEX; BLOOD PRESSURE; CARDIOVASCULAR RISK; FOLLOW UP; HYPERTENSION; KIDNEY DENERVATION; KIDNEY NERVE; KIDNEY NERVE ABLATION; NOTE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RESISTANT HYPERTENSION; SYMPATHETIC FUNCTION; SYMPATHETIC NERVE;

DENERVATION; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE;

EID: 84884176263     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328363533c     Document Type: Note

References (16)

1. Krum H, Schlaich M, Whitbourn R., Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-1281.
2. Winternitz SR, Oparil S. Importance of renal nerves in the pathogenesis of experimental hypertension. Hypertension 1982; 4 (5 Pt 2):III108-III114.
3. Stella A, Zanchetti A. Interactions between the sympathetic nervous system and the kidney: experimental observations. J Hypertens 1985; 3 (SUPPL. 1):S19-S25.
4. Esler M. The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascualr disease: the transition from mechanisms to medical management. J Appl Physiol 2010; 108:227-237.
5. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23:1052-1058.
6. Blacher J, Guerin AP, Pannier B, Marchais S.J., Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99:2434-2439.
7. Laurent S, Boutouyrie P, Asmar R., Gautier I, Laloux B, Guize L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
8. Vlachopoulos C, Aznaouridis K, Stefanidis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-1327.
9. Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton A.S., Krum H., et al. Renal nerve ablation reduces augmentation index in patients with resistant hypertension. J Hypertens 2013; 31:1893-1900.
10. Pickering TG. Arterial stiffness as a cause of resistant hypertension. J Clin Hypertens (Greenwich) 2007; 9:390-395.
11. Seravalle G, Volpe M, Ganz F., Magni L, Brambilla G, Dell'Oro R, et al. Neuroadrenergic profile in patients with resistant hypertension. J Hypertens 2011; 29:e141; (Abstract).
12. Boutouyrie P, Lacolley P, Girerd X., Beck L, Safar M, Laurent S. Sympathetic activation decreases medium-sized arterial compliance in humans. Am J Physiol 1994; 267:H1368-H1376.
13. Grassi G, Giannattasio C, Failla M., Pesenti A, Peretti G, Marinoni E., et al. Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 1995; 26:348-354.
14. Giannattasio C, Failla M, Lucchina S., Zazzeron C, Scotti V, Capra A., et al. Arterial stiffening influence of sympathetic nerve activity: evidence from hand transplantation in humans. Hypertension 2005; 45:608-611.
15. Triposkiadis F, Karayannis G, Giamouzis G., Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009; 54:1747-1762.
16. Mancia G, Grassi G. Management of essential hypertension. Br Med Bull 2010; 94:189-199.